Schonfeld Strategic Advisors’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4M | Sell |
3,049,891
-794,976
| -21% | -$2.97M | 0.08% | 264 |
|
|
2025
Q1 | $10.6M | Sell |
3,844,867
-906,639
| -19% | -$2.5M | 0.06% | 263 |
|
|
2024
Q4 | $26.3M | Buy |
4,751,506
+1,461,680
| +44% | +$8.1M | 0.15% | 99 |
|
|
2024
Q3 | $27.4M | Buy |
3,289,826
+1,021,398
| +45% | +$8.52M | 0.18% | 64 |
|
|
2024
Q2 | $15.4M | Buy |
2,268,428
+1,072,634
| +90% | +$7.3M | 0.1% | 204 |
|
|
2024
Q1 | $7.84M | Buy |
1,195,794
+787,936
| +193% | +$5.17M | 0.05% | 403 |
|
|
2023
Q4 | $2.65M | Buy |
407,858
+316,450
| +346% | +$2.05M | 0.02% | 650 |
|
|
2023
Q3 | $460K | Sell |
91,408
-27,528
| -23% | -$138K | ﹤0.01% | 1101 |
|
|
2023
Q2 | $1.04M | Buy |
118,936
+3,684
| +3% | +$32.2K | 0.01% | 944 |
|
|
2023
Q1 | $1.36M | Buy |
+115,252
| New | +$1.36M | 0.01% | 815 |
|